Type of leukemia-Chronic lymphocytic leukemia (CLL) Posts on Medivizor
Navigation Menu

Type of leukemia-Chronic lymphocytic leukemia (CLL) Posts on Medivizor

Comparing chemoimmunotherapy and ibrutinib treatment in patients with chronic lymphocytic leukemia

Posted by on Sep 7, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to compare the outcomes of patients with chronic lymphocytic leukemia who received chemoimmunotherapy or ibrutinib. This study suggested that ibrutinib may have more favorable outcomes for these patients when compared to chemoimmunotherapy. Some background Chemoimmunotherapy (CIT) is a treatment option that can be used...

Read More

The effect of other conditions on ibrutinib treatment of CLL

Posted by on Jun 26, 2018 in Leukemia | 0 comments

In a nutshell The study looked at the impact of other medical conditions (comorbidities) on the effectiveness of ibrutinib (Imbruvica) in the treatment of chronic lymphocytic leukemia (CLL). The study concluded that having a number of other conditions was associated with a poorer prognosis in CLL patients treated with ibrutinib. Some background...

Read More

Combining obinutuzumab and bendamustine for chronic lymphocytic leukemia patients

Posted by on Jun 23, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness of an obinutuzumab and bendamustine combination in chronic lymphocytic leukemia patients. This study concluded that this combination appears to be effective in these patients and has manageable side effects. Some background Obinutuzumab (Gazyva) is a monoclonal antibody. Monoclonal...

Read More

Lenalidomide and blood clots: low risk in CLL and NHL

Posted by on May 22, 2018 in Leukemia | 0 comments

In a nutshell This study examined the risk of venous thromboembolism (VTE, a blood clot that forms in the veins of the legs, arms, or groin) in patients treated with lenalidomide (Revlimid). The study concluded that the risk of VTE was low with lenalidomide treatment. Some background Lenalidomide is an effective treatment already used in multiple...

Read More

A new treatment combination for patients with relapsed/refractory chronic lymphocytic leukemia

Posted by on Apr 18, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness of venetoclax (Venclexta) and rituximab (Rituxan) treatment in patients with relapsed/refractory chronic lymphocytic leukemia. This study concluded that venetoclax-rituximab treatment was effective for these patients.     Some background Chronic lymphocytic leukemia...

Read More

First-line treatment with ibrutinib – a review

Posted by on Mar 11, 2018 in Leukemia | 0 comments

In a nutshell This study outlined recent evidence on the use of ibrutinib (Imbruvica) for chronic lymphocytic leukemia (CLL). Some background Tyrosine kinase inhibitor therapy is a type of immunotherapy that blocks signals needed for tumors to grow. This includes the Bruton tyrosine kinase inhibitor ibrutinib. Ibrutinib blocks a signal that keeps the...

Read More